| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3696988
Max Phase: Preclinical
Molecular Formula: C19H21N3O5
Molecular Weight: 371.39
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CNC(=O)C(C(=O)NO)N(C)C(=O)c1ccc(-c2ccc(OC)cc2)cc1
Standard InChI: InChI=1S/C19H21N3O5/c1-20-17(23)16(18(24)21-26)22(2)19(25)14-6-4-12(5-7-14)13-8-10-15(27-3)11-9-13/h4-11,16,26H,1-3H3,(H,20,23)(H,21,24)
Standard InChI Key: OFLQCPWLICIXKZ-UHFFFAOYSA-N
Associated Targets(non-human)
UDP-3-O-acyl-GlcNAc deacetylase 700 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 371.39 | Molecular Weight (Monoisotopic): 371.1481 | AlogP: 1.05 | #Rotatable Bonds: 6 |
| Polar Surface Area: 107.97 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.64 | CX Basic pKa: | CX LogP: 0.84 | CX LogD: 0.82 |
| Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.40 | Np Likeness Score: -0.51 |
References
| 1. (2015) Hydroxamic acid derivative, |
Source
Source(1):